Rilutek (riluzole) tablets, the first drug approved for amyotrophic lateral sclerosis

Rhone-Poulenc Rorer is now marketing Rilutek (riluzole) tablets, the first drug approved for amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

ALS is a progressive, degenerative disease of the nerves. It leads to muscle weakness...paralysis...and eventually death.

ALS is thought to be caused by excess glutamate...an excitatory neurotransmitter that causes nerve damage.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote